{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "David A. Griffith", "item": "https://www.patentleaderboard.com/2021/inventor/fl:da_ln:griffith-7"}]}

Home › 2021 › Pfizer › David A. Griffith

David A. Griffith — 2 Patents in 2021

Pfizer: 2 patents #36 of 325Top 15%

Sudbury, MA: #34 of 146 inventorsTop 25%

Massachusetts: #2,417 of 14,123 inventorsTop 20%

Overall (2021): #169,439 of 548,734Top 35%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11059833	BCKDK inhibitors	Samit Kumar Bhattacharya, Leanne Marie Buzon, Kevin James Filipski, Bethany Lyn Kormos, Luis Angel Martinez-Alsina +4 more	2021-07-13	$442,539,000
10934279	GLP-1 receptor agonists and uses thereof	Gary Erik Aspnes, Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan +8 more	2021-03-02	$1,471,575,000

David A. Griffith — 2 Patents in 2021

Issued Patents 2021

Patent Widget